| 000 | 01942cam a22004458a 4500 | ||
|---|---|---|---|
| 001 | 16706676 | ||
| 003 | The World Bank | ||
| 005 | 20130515013720.0 | ||
| 006 | m d | ||
| 007 | cr cn||||||||| | ||
| 008 | 110317s2011 dcu b 001 0 eng | ||
| 010 | _a2011012020 | ||
| 020 | _a9780821387603 | ||
| 020 | _a9780821387719 (eISBN) | ||
| 035 | _a(DNLM)101556613 | ||
| 035 | _a(The World Bank)16706676 | ||
| 040 |
_aDNLM/DLC _cDLC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRA401.A1 _bR63 2011 |
| 060 | 1 | 0 | _aQV 736 |
| 082 | 0 | 0 |
_a615.1 _222 |
| 100 | 1 | _aRoberts, Marc J. | |
| 245 | 1 | 0 |
_aPharmaceutical reform : _ba guide to improving performance and equity / _cby Marc J. Roberts and Michael R. Reich. |
| 260 |
_aWashington, D.C. : _bWorld Bank, _cc2011. |
||
| 263 | _a1107 | ||
| 300 |
_ap. ; _ccm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aIntroduction -- Using the flagship framework to reform pharmaceutical policy -- Introduction to the pharmaceutical sector -- Ethics and priority setting in pharmaceutical reform -- Diagnosing performance problems and developing a policy response -- Managing the politics of pharmaceutical policy reform -- Financing the pharmaceutical sector -- Paying for pharmaceuticals -- Organizing the public sector to improve pharmaceutical performance -- Improving pharmaceutical performance through regulation -- Using persuasion to influence pharmaceutical use -- Conclusions. | |
| 650 | 1 | 2 |
_aDrug Industry _xorganization & administration. |
| 650 | 2 | 2 |
_aHealth Care Reform _xorganization & administration. |
| 650 | 2 | 2 | _aPharmaceutical Preparations. |
| 650 | 0 | _aHealth care reform. | |
| 650 | 0 | _aPharmaceutical industry. | |
| 650 | 0 | _aPharmaceutical policy. | |
| 700 | 1 |
_aReich, Michael, _d1950- |
|
| 710 | 2 | _aWorld Bank. | |
| 830 | 0 | _aWorld Bank e-Library. | |
| 856 | 4 | 0 | _uhttp://elibrary.worldbank.org/content/book/9780821387603 |
| 942 |
_2ddc _cSL |
||
| 999 |
_c2 _d2 |
||